who do you want to deputize to either file personally or approach any BP industry leader to produce such an amicus brief in the sort time frame remaining?[/quoand. None of us, IMO but as MRM wrote:
ADA, ACC, AHA, ICER, the USPTO, and any BP that doesn't want to be sitting in Amarin's spot when generics come for their new drug using.
If none of them file one, then perhaps someone should contact Amarin and ask if investors can / should...?